Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group

PURPOSE: Highly sensitized patients with a high level of panel reactive antibody (PRA) experience more episodes of antibody-mediated rejection (AMR) and poorer graft survival than non-sensitized patients. Rituximab is a well-known monoclonal anti-CD20 antibody that causes the depletion of B lymphocy...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Song, Young Hae, Huh, Kyu Ha, Kim, Yu Seun, Lee, Hyung Soon, Kim, Myoung Soo, Kim, Soo Jin, Kim, Hyun Jung, Kim, Soon Il, Joo, Dong Jin
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Surgical Society 2012
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3373982/
https://ncbi.nlm.nih.gov/pubmed/22708094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/jkss.2012.82.6.335
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky